F049 Translating Evidence into Practice: Atopic Dermatitis Guidelines
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will focus on recent developments in atopic dermatitis and how they affect our clinical practice. Specific talks will be devoted to deciphering new associations and co-morbidities; understanding the evidence behind newer therapies particularly biologics; and plumbing for clinical pearls that may slip between the cracks of the "evidence."
LEARNING OBJECTIVES
Highlight newest systemic therapy options for atopic dermatitis.
Discuss newest topical therapies for atopic dermatitis and how they fit into therapeutic armamentarium.
Review newer associations and co-morbidities and discuss clinical implications.
SCHEDULE
5:00 PM
Introduction
Robert Sidbury, MD, MPH, FAAD
5:05 PM
Comorbidity Update
Dawn M.R. Davis, MD, FAAD
5:30 PM
Topical Therapy
Lawrence F Eichenfield, MD, FAAD
6:00 PM
Systemic Therapy
David Eric Cohen, MD, FAAD
6:30 PM
The Rest of the Story
Robert Sidbury, MD, MPH, FAAD
SPEAKERS
David Eric Cohen, MD, FAAD
Dawn M.R. Davis, MD, FAAD
Lawrence F Eichenfield, MD, FAAD
Robert Sidbury, MD, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
David Eric Cohen, MD, FAAD
Cosmetic Ingredient Review – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Dermira – Board of Directors(Stock); Evommune, Inc. – Board of Directors(Fees), Board of Directors(Stock Options); Facilitation of International Dermatology Education – Consultant(Honoraria); Ferndale Laboratories, Inc. – Consultant(Honoraria); Kadmon Corporation, LLC – Board of Directors(Fees), Board of Directors(Stock Options); LEO Laboratories Ltd (LEO Pharma) – Consultant(Honoraria); Medimetriks Pharmaceuticals, Inc. – Consultant(Honoraria); Novartis – Consultant(Honoraria); SFJ Pharmaceuticals – Consultant(Honoraria); Timber Pharmaceuticals – Board of Directors(Fees), Board of Directors(Stock Options); UCB – Consultant(Honoraria);
Dawn M.R. Davis, MD, FAAD
No financial relationships exist with ineligible companies.
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Nobelpharma – Consultant(Honoraria); Ortho Dermatologics – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); TopMD – Consultant(Stock Options); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Robert Sidbury, MD, MPH, FAAD
Arcutis, Inc. – Advisory Board(Honoraria); Beiersdorf, Inc. – Speaker/Faculty Education(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Dermavent – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma Global – Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received); UCB – Investigator(Grants/Research Funding);